Skip to content

Homeopathic medicines for ringworm

Efficacy of individualized homeopathic medicines in tinea corporis: double-blind, randomized, placebo-controlled trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021999
Enrollment
62
Registered
2019-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Individualized homeopathic medicines in 50 millesimal potencies, as decided appropriate to the case or condition: Intervention is planned as administering individualized homeopathic med
16 doses to be marked on the vial

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from tinea corporis since last 3 months 2. Age 18-65 years 3. Both sexes 4. Literate patients; ability to read English and/or Bengali 5. Providing written informed consent 6. Patient using antifungal agents for tinea lesions will be included after a washout period of four weeks

Exclusion criteria

Exclusion criteria: 1. Cases with complication like lichenification and eczematisation 2. Similar looking skin conditions; e.g. seborrhic dermatitis, pityriasis rosea and psoriasis 3. Patients who are too sick for consultation, unable to read patient information sheet, unwilling to take part or not giving consent to join the study 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 5. Pregnant women and lactating mothers 6. Substance abuse and/or dependence 7. Self-reported immune-compromised state, and 8. Already undergoing homeopathic treatment for chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Number of patients in each group showing complete disappearance of the skin lesion over 3 months of interventionTimepoint: Baseline, every month, up to 3 months

Secondary

MeasureTime frame
Intensity of pruritus measured by 0-10 numeric rating scalesTimepoint: Baseline, every month, up to 3 months;Skindex-29 questionnaireTimepoint: Baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactSwapan Paul

National Institute of Homoeopathy

drspaul.2007@gmail.com9830148968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 11, 2026